Biomedical and public health research have led to many fundamental and lifesaving discoveries. However, the growth of research production also generates many non-repeatable results. The lack of reproducibility is a form of waste that burdens the system without adding value to society. Non-repeatable research is damaging to the entire scientific community. Not only does it waste money and time but it can cause stress and heartbreak for patients and families looking for hope or a cure.
Dr. Andrew Balas, professor at Augusta University MPH Program has taken a special interest in research innovation and quality improvement in the research enterprise. He recently published a correspondence article in the journal Nature, titled “Preclinical data: Three-point plan for reproducibility.”
Dr. Balas and co-author Dr. Lee Ellis from MD Anderson provide a new framework for the prevention of non-repeatable research. The three-tiered approach aims to ensure the reproducibility of preclinical research results that provide essential information for the launching of clinical studies and ultimately for the development of new products and services for patient care. The tiers include transparency, replication and triangulation which should be attained prior to publication.
The journal, Nature, is the world’s most highly cited interdisciplinary science journal. The weekly journal swiftly publishes premium peer-reviewed research in all fields of science and technology